🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#AI has developed many applications used in medicine, such as in the case of patients with breast cancer. But for such systems to be effective, they must be safe, equitable and needs-focused, explains Oriana Ciani via Medium medium.com/@bocconiuniver…

📢New publication in the Journal of Clinical Epidemiology as part of the SPIRIT|CONSORT-Surrogate project Definitions, acceptability, limitations, and guidance in the use and reporting of #surrogateendpoints in #RCTs: A scoping review doi.org/10.1016/j.jcli…

New #research in BMC with Oriana Ciani Vittoria Ardito on patient #engagement in #deciding own #treatment. Here, we review available evidence on how to implement interventions supporting shared decision-making in #breastcancer care. Read here rdcu.be/dkjQ9

Yesterday we had the second consortium meeting of HI-PRIX #horizoneurope project to discuss progress achieved so far! Interesting presentations on WP1, WP2 and WP3 Oriana Ciani Silvia Giopp SDA Bocconi #cergas

A framework for the definition and interpretation of the use of surrogate endpoints in RCT sciencedirect.com/science/articl… Very important work! I am very proud to contribute to this fundamental work Gary Collins Oriana Ciani Joseph Ross anthony Muchai Manyara SCTorg Improving Health.

📢NEW Publication in eClinicalMedicine – The Lancet Discovery Science as part of the SPIRIT|CONSORT-Surrogate Project A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials sciencedirect.com/science/articl…

#ISPOREurope 2023 Poster 1/2 - Methods to measure the environmental impacts of health technologies and to include them in economic evaluations: A scoping literature review HI-PRIX #cergas #ispor

#ISPOREurope 2023 Poster 2/2 - Investigating the nature and scope of innovative payment and pricing schemes for health technologies HI-PRIX #cergas #ispor

Interesting funded PhD opportunity on Surrogate endpoints for cancer screening trials. ⏩ Deadline for application: January 15, 2024

The #PRO4All team has worked hard in the past years to generate evidence and propose actions to promote #patientengagement in the #healthcare We are proud to see some of our proposals embraced unanimously by decision-makers SDA Bocconi

📢 The CINDERELLA Clinical Trial presentation video is out! It offers a sneak peek into our innovative trial for breast cancer surgery. 🎥youtu.be/O7-6BZDjcqQ The trial, evaluating an AI-based tool's impact on clinical decisions is ongoing at 6 clinical centres worldwide.

Very interesting project discussing barriers to implementing #PROs in routine care for pts with cancer. We are aware that ESMO - Eur. Oncology guideline is among the least applied in practice, at the moment. It will be interesting to see the trend in the next 3-5 years, hopefully improving.

New Yale CRRIT paper in JAMA: Most surrogate markers used to support FDA approval of drugs treating nononcologic chronic diseases lack high-strength evidence of associations w/ clinical outcomes from published meta-analyses. 1/13 jamanetwork.com/journals/jama/…

Day II of the HI-PRIX-Consortium meeting 2024 at the #HCHE in Hamburg! Experts from Italy, Austria, Spain, the Netherlands, UK, Portugal, Belgium, France and Germany discussing new ideas for health innovation in the EU. Office of Health Economics 📷HCHE/Rathjen

Really excited to serve as guest editor for BMC Digital Health's collection on digital health economics! Call for papers out and available at tinyurl.com/39p3n7pc

Have a look to this paper on Eur J Cancer by the Italian #PRO4All project, to help researchers choosing #PROMs for pts with cancer The development of an Archive of Patient-Reported Outcome Measures (PROMs) in Oncology: The Italian PRO4All Project ejcancer.com/article/S0959-…

This article describes the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials)-Surrogate extension, a guideline to improve reporting of trial protocols using a surrogate endpoint as a primary outcome, Oriana Ciani bmj.com/content/386/bm…

This article describes the CONSORT-Surrogate (Consolidated Standards of Reporting Trials) extension, a guideline to improve reporting of trial reports using a surrogate endpoint as a primary outcome, Oriana Ciani bmj.com/content/386/bm…

🎉 Exciting News! 🎉 I’m happy to share that my first PhD paper, "Design and Features of Pricing and Payment Schemes for Health Technologies: A Scoping Review and a Proposal for a Flexible Need-Driven Classification", is published in PharmacoEconomics! doi.org/10.1007/s40273…

Editorial from Rod Taylor, anthony Muchai Manyara, Joseph Ross, and Oriana Ciani describes the use of surrogate end points and provides new guidance for reporting studies with surrogate outcomes. #JAMASummit ja.ma/4eYIjLy